CA Final · Integrated Business Solutions (Multidisciplinary Case Study with Strategic Management) · Corporate and Economic Laws
Case: Orion Steels Ltd, a company with a Rs 500 crore turnover, also has a related Competition Commission inquiry. Orion holds a 70% market share in specialised alloy rods and charges lower prices only to buyers who agree not to purchase from rival makers. Dealer Mehta complains. Under the Competition Act, 2002, which best characterises Orion's conduct?
Orion's conduct can amount to abuse of a dominant position. Dominance is not itself prohibited, but giving lower prices only to buyers who avoid rivals is an exclusionary practice. The Commission must first define the relevant market and establish dominance. No agreement among competitors exists, so it is not a cartel.
- ANot an offence as having a dominant position is itself prohibited and fined without examining conduct
- BA prohibited cartel because it involves price fixing among competitors
- CA permitted vertical agreement as dealers consent to it
- DPossible abuse of dominant position, as conditioning supply on exclusivity can be an unfair or exclusionary practice, once dominance in the relevant market is establishedCorrect
Explanation
Dominance itself is not prohibited; abuse of it is. Making buyers agree not to deal with rivals is an exclusionary practice that the Commission may treat as abuse, after defining the relevant market and finding dominance. It is not a cartel, since no agreement among competitors is described, and dealer consent does not legitimise abuse.
Did you get it right without looking?
One question tells you little. A timed set on Corporate and Economic Laws shows your real accuracy, how long you take and where you lose marks.
More Corporate and Economic Laws questions
- Case: Vihaan Steels Ltd, a public company, had Rs 10 crore paid-up capital and a creditor, Orbit Metals, owed Rs 3 crore. Vihaan's bank, Nat…
- Case: Surya Components Ltd's Board of 9 directors includes a nominee of a lender, and the company has accumulated losses. The CFO proposes t…
- Case: Vihaan Pharma Ltd imports raw materials priced in US dollars. Its CFO says a rise in the repo rate and a depreciating rupee will both …
- Case: Bharat Pharma Ltd, a company in Hyderabad, receives a foreign remittance from a US investor for Rs 40 crore in exchange for equity sha…
- Case: Sundaram Pharma Ltd, a listed company, proposes to buy back its own equity shares out of free reserves. Its paid-up capital is Rs 40 c…
- Case: Kaveri Agro Foods Ltd, an unlisted public company, has paid-up capital of Rs 40 crore. Its Board wants to issue shares to a few identi…